Published in Mult Scler on March 09, 2010
Penalized functional regression analysis of white-matter tract profiles in multiple sclerosis. Neuroimage (2011) 1.26
A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology. Brain (2012) 1.22
Tracking cerebral white matter changes across the lifespan: insights from diffusion tensor imaging studies. J Neural Transm (Vienna) (2013) 1.02
Altered inter-subregion connectivity of the default mode network in relapsing remitting multiple sclerosis: a functional and structural connectivity study. PLoS One (2014) 0.87
Functional topography of the corpus callosum investigated by DTI and fMRI. World J Radiol (2014) 0.82
Diffuse and focal corticospinal tract disease and its impact on patient disability in multiple sclerosis. J Neuroimaging (2014) 0.81
Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI. Hum Brain Mapp (2012) 0.80
Modeling the relationship among gray matter atrophy, abnormalities in connecting white matter, and cognitive performance in early multiple sclerosis. AJNR Am J Neuroradiol (2014) 0.80
Determinants of disability in multiple sclerosis: an immunological and MRI study. Biomed Res Int (2014) 0.78
Depressive symptoms in multiple sclerosis from an in vivo study with TBSS. Biomed Res Int (2014) 0.77
Is the Relationship between Cortical and White Matter Pathologic Changes in Multiple Sclerosis Spatially Specific? A Multimodal 7-T and 3-T MR Imaging Study with Surface and Tract-based Analysis. Radiology (2015) 0.76
Intrinsic Functional Plasticity of the Thalamocortical System in Minimally Disabled Patients with Relapsing-Remitting Multiple Sclerosis. Front Hum Neurosci (2016) 0.75
How changes in brain activity and connectivity are associated with motor performance in people with MS. Neuroimage Clin (2017) 0.75
The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis. Front Neurol (2017) 0.75
Fast robust automated brain extraction. Hum Brain Mapp (2002) 41.79
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology (1983) 40.64
Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage (1999) 40.38
Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage (1999) 29.82
A global optimisation method for robust affine registration of brain images. Med Image Anal (2001) 27.87
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage (2006) 25.52
Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging (2001) 25.22
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol (2005) 24.22
No adjustments are needed for multiple comparisons. Epidemiology (1990) 23.80
Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A (2000) 19.87
High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp (1999) 16.32
Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn Reson Med (2003) 12.09
Sequence-independent segmentation of magnetic resonance images. Neuroimage (2004) 11.36
A hybrid approach to the skull stripping problem in MRI. Neuroimage (2004) 9.59
Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging. Magn Reson Med (1999) 8.94
Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage (2005) 8.50
Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging (2001) 8.14
Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage (2006) 7.14
Functional-anatomical validation and individual variation of diffusion tractography-based segmentation of the human thalamus. Cereb Cortex (2004) 3.03
High consistency of regional cortical thinning in aging across multiple samples. Cereb Cortex (2009) 2.88
Focal thinning of the cerebral cortex in multiple sclerosis. Brain (2003) 2.74
Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain (2008) 2.40
Diffusion tensor imaging of post mortem multiple sclerosis brain. Neuroimage (2006) 2.35
Diffusion-based tractography in neurological disorders: concepts, applications, and future developments. Lancet Neurol (2008) 2.13
Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology (2006) 2.10
Grey matter pathology in multiple sclerosis. Lancet Neurol (2008) 1.97
Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. Brain (2008) 1.84
Combined functional MRI and tractography to demonstrate the connectivity of the human primary motor cortex in vivo. Neuroimage (2003) 1.69
Multiparametric magnetic resonance imaging analysis of the corticospinal tract in multiple sclerosis. Neuroimage (2007) 1.62
The evolution of prefrontal inputs to the cortico-pontine system: diffusion imaging evidence from Macaque monkeys and humans. Cereb Cortex (2005) 1.61
Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis. Brain (2007) 1.55
Validation of in vitro probabilistic tractography. Neuroimage (2007) 1.54
Pyramidal tract mapping by diffusion tensor magnetic resonance imaging in multiple sclerosis: improving correlations with disability. J Neurol Neurosurg Psychiatry (2003) 1.53
Probabilistic diffusion tractography: a potential tool to assess the rate of disease progression in amyotrophic lateral sclerosis. Brain (2006) 1.53
Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability. Neuroimage (2006) 1.40
Upper extremity function in multiple sclerosis: improving assessment sensitivity with box-and-block and nine-hole peg tests. Arch Phys Med Rehabil (1988) 1.28
Accumulation of cortical lesions in MS: relation with cognitive impairment. Mult Scler (2009) 1.27
Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM. Hum Brain Mapp (2009) 1.22
Discordant white matter N-acetylasparate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis. Neuroimage (2007) 1.19
Corticospinal tract abnormalities are associated with weakness in multiple sclerosis. AJNR Am J Neuroradiol (2007) 1.17
Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol (1997) 1.15
Relating neocortical pathology to disability progression in multiple sclerosis using MRI. Neuroimage (2004) 1.12
Gray matter pathology in (chronic) MS: modern views on an early observation. J Neurol Sci (2009) 1.11
Structural plasticity: rewiring the brain. Curr Biol (2007) 1.09
A Wallerian degeneration pattern in patients at risk for MS. Neurology (2000) 1.08
Diffusion tensor tractography-based group mapping of the pyramidal tract in relapsing-remitting multiple sclerosis patients. AJNR Am J Neuroradiol (2007) 1.07
Functional brain reorganization for hand movement in patients with multiple sclerosis: defining distinct effects of injury and disability. Brain (2002) 1.05
The natural history of relapses in multiple sclerosis. J Neurol Sci (2007) 1.05
Functional brain reorganization in multiple sclerosis: evidence from fMRI studies. J Neuroimaging (2006) 1.04
Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging. J Neurol Sci (2009) 1.00
Localization of functional regions of human mesial cortex by somatosensory evoked potential recording and by cortical stimulation. Electroencephalogr Clin Neurophysiol (1996) 0.89
Motor reorganization in multiple sclerosis. Neurol Res (2007) 0.78
Reduced cortical surface area in multiple sclerosis. Neurol Res (2007) 0.77
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol (2011) 25.66
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol (2005) 24.22
Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage (2006) 23.57
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med (2006) 11.29
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. N Engl J Med (2012) 6.51
A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med (2002) 3.74
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet (2008) 3.68
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol (2007) 3.47
Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol (2005) 3.45
A framework for a streamline-based probabilistic index of connectivity (PICo) using a structural interpretation of MRI diffusion measurements. J Magn Reson Imaging (2003) 3.43
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurol (2009) 3.42
Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol (2004) 3.23
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol (2012) 3.15
Functional-anatomical validation and individual variation of diffusion tractography-based segmentation of the human thalamus. Cereb Cortex (2004) 3.03
Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations. Lancet Neurol (2007) 2.53
Hemispheric asymmetries in language-related pathways: a combined functional MRI and tractography study. Neuroimage (2006) 2.49
Lateralization of ventral and dorsal auditory-language pathways in the human brain. Neuroimage (2004) 2.46
The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy. J Neurol (2005) 2.44
MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation". Lancet Neurol (2006) 2.44
Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol (2009) 2.43
Estimating distributed anatomical connectivity using fast marching methods and diffusion tensor imaging. IEEE Trans Med Imaging (2002) 2.38
Diffusion tensor imaging of post mortem multiple sclerosis brain. Neuroimage (2006) 2.35
Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain (2002) 2.30
Neuroplasticity predicts outcome of optic neuritis independent of tissue damage. Ann Neurol (2010) 2.24
An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. Brain (2007) 2.18
Initial demonstration of in vivo tracing of axonal projections in the macaque brain and comparison with the human brain using diffusion tensor imaging and fast marching tractography. Neuroimage (2002) 2.14
MRI in multiple sclerosis: current status and future prospects. Lancet Neurol (2008) 2.08
Lack of association between antimyelin antibodies and progression to multiple sclerosis. N Engl J Med (2007) 2.06
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Neurol (2010) 2.03
Quality of life measurement after stroke: uses and abuses of the SF-36. Stroke (2002) 2.00
Motor system activation after subcortical stroke depends on corticospinal system integrity. Brain (2006) 1.99
Degradability of an acrylate-linked, fluorotelomer polymer in soil. Environ Sci Technol (2009) 1.96
Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol (2008) 1.91
Health-related quality of life in multiple sclerosis: effects of natalizumab. Ann Neurol (2007) 1.88
Quantitative magnetic resonance of postmortem multiple sclerosis brain before and after fixation. Magn Reson Med (2008) 1.82
Investigating cervical spinal cord structure using axial diffusion tensor imaging. Neuroimage (2002) 1.76
Setting a research agenda for progressive multiple sclerosis: the International Collaborative on Progressive MS. Mult Scler (2012) 1.75
Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain (2004) 1.71
Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol (2012) 1.70
Effect sizes can be misleading: is it time to change the way we measure change? J Neurol Neurosurg Psychiatry (2010) 1.70
Combined functional MRI and tractography to demonstrate the connectivity of the human primary motor cortex in vivo. Neuroimage (2003) 1.69
New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes. Ann Neurol (2003) 1.66
Low-grade gliomas: six-month tumor growth predicts patient outcome better than admission tumor volume, relative cerebral blood volume, and apparent diffusion coefficient. Radiology (2009) 1.66
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain (2003) 1.62
The evolution of prefrontal inputs to the cortico-pontine system: diffusion imaging evidence from Macaque monkeys and humans. Cereb Cortex (2005) 1.61
Clinically isolated syndromes. Lancet Neurol (2012) 1.59
Patient-based outcomes of cervical dystonia: a review of rating scales. Mov Disord (2004) 1.59
Disability, atrophy and cortical reorganization following spinal cord injury. Brain (2011) 1.58
Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis. Neurology (2012) 1.57
Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol (2002) 1.57
Exploring rating scale responsiveness: does the total score reflect the sum of its parts? Neurology (2004) 1.54
Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes. J Magn Reson Imaging (2010) 1.54
Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain. J Magn Reson Imaging (2007) 1.54
Optic nerve diffusion tensor imaging in optic neuritis. Neuroimage (2005) 1.54
Characterizing function-structure relationships in the human visual system with functional MRI and diffusion tensor imaging. Neuroimage (2004) 1.52
The therapeutic potential of cannabis. Lancet Neurol (2003) 1.49
A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials. Brain (2010) 1.48
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL. J Neurol (2009) 1.46
Development of a high-resolution fat and CSF-suppressed optic nerve DTI protocol at 3T: application in multiple sclerosis. Funct Neurol (2013) 1.46
Functional anatomy of interhemispheric cortical connections in the human brain. J Anat (2006) 1.45
High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis. Brain (2010) 1.42
Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage (2006) 1.41